DocStoX is a free AI-powered research platform for Indian equity markets, covering 5,700+ NSE & BSE stocks with prices, fundamentals, 326 financial ratios, shareholding, FII/DII flows, F&O, IPOs, a visual screener and AI stock scoring.

Yes. DocStoX has a free tier covering stock research, the screener, FII/DII data and educational guides, plus a free MCP API tier (50 tool calls/day) for AI assistants. A Pro plan adds higher limits and advanced features.

What data does DocStoX cover?

Every NSE & BSE listed stock (5,700+ instruments): EOD and intraday prices, income statement / balance sheet / cash flow, 326 ratios, quarterly shareholding, promoter pledge, mutual-fund holdings, FII/DII flows, F&O and option-chain data, analyst forecasts, IPOs, corporate actions and news.

Can AI assistants like ChatGPT or Claude use DocStoX data?

Yes. DocStoX runs a public Model Context Protocol (MCP) server at https://mcp.docstox.com/mcp with 76 tools, so Claude, ChatGPT, Cursor and other MCP clients can pull Indian market data directly. Setup and a free key are at https://docstox.com/mcp.

Neutral impactResults

Banswara Syntex Q2 FY27: Date and Outlook

Univest 7 hrs ago·9 Sept 2026, 11:48 am

Banswara Syntex has announced the date for its Q2 FY27 earnings release, marking the next key milestone for the company. Investors will receive the official financial results and management commentary on the business's performance during this period.

This update is significant as it provides clarity on the company's operational health and future trajectory. The results will likely offer insights into Banswara Syntex's ability to navigate the current market environment and sustain its growth momentum.

Investors should focus on the company's revenue growth, profit margins, and any guidance provided by management regarding the outlook for the upcoming quarters. These factors will be crucial in determining the stock's future direction.